1. Home
  2. AIP vs ABEO Comparison

AIP vs ABEO Comparison

Compare AIP & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIP
  • ABEO
  • Stock Information
  • Founded
  • AIP 2003
  • ABEO 1974
  • Country
  • AIP United States
  • ABEO United States
  • Employees
  • AIP N/A
  • ABEO N/A
  • Industry
  • AIP Semiconductors
  • ABEO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AIP Technology
  • ABEO Health Care
  • Exchange
  • AIP Nasdaq
  • ABEO Nasdaq
  • Market Cap
  • AIP 400.9M
  • ABEO 332.0M
  • IPO Year
  • AIP 2021
  • ABEO 1980
  • Fundamental
  • Price
  • AIP $9.30
  • ABEO $6.26
  • Analyst Decision
  • AIP Strong Buy
  • ABEO Strong Buy
  • Analyst Count
  • AIP 3
  • ABEO 6
  • Target Price
  • AIP $15.00
  • ABEO $18.00
  • AVG Volume (30 Days)
  • AIP 2.0M
  • ABEO 611.9K
  • Earning Date
  • AIP 08-05-2025
  • ABEO 08-19-2025
  • Dividend Yield
  • AIP N/A
  • ABEO N/A
  • EPS Growth
  • AIP N/A
  • ABEO N/A
  • EPS
  • AIP N/A
  • ABEO N/A
  • Revenue
  • AIP $63,236,000.00
  • ABEO N/A
  • Revenue This Year
  • AIP $19.82
  • ABEO N/A
  • Revenue Next Year
  • AIP $17.29
  • ABEO $322.37
  • P/E Ratio
  • AIP N/A
  • ABEO N/A
  • Revenue Growth
  • AIP 18.64
  • ABEO N/A
  • 52 Week Low
  • AIP $5.46
  • ABEO $3.93
  • 52 Week High
  • AIP $14.29
  • ABEO $7.32
  • Technical
  • Relative Strength Index (RSI)
  • AIP 48.33
  • ABEO 47.50
  • Support Level
  • AIP $8.76
  • ABEO $6.18
  • Resistance Level
  • AIP $14.29
  • ABEO $6.94
  • Average True Range (ATR)
  • AIP 0.84
  • ABEO 0.27
  • MACD
  • AIP -0.07
  • ABEO -0.05
  • Stochastic Oscillator
  • AIP 9.76
  • ABEO 18.07

About AIP Arteris Inc.

Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: